Biochemical and Biophysical Research Communications
UAP56 is an important regulator of protein synthesis and growth in cardiomyocytes
Introduction
Cardiac hypertrophy occurs in response to various factors including mechanical, hemodynamic and pathological stimuli [1]. While this response is initially adaptive, it can result in pathologic hypertrophy and subsequent heart failure. Regression or inhibition of cardiac hypertrophy may lead to improved outcomes as was the case in the HOPE trial in which the angiotensin converting enzyme (ACE) inhibitor ramipril was shown to decrease the development of and cause regression of electrocardiographic markers of left ventricular hypertrophy (LVH) [2]. These changes were independent of blood pressure reduction and were associated with reduced risk of death, myocardial infarction, stroke and congestive heart failure. Enhanced protein synthesis is a critical component of cardiac hypertrophy. Cardiac hypertrophy in vivo, and cardiac myocyte hypertrophy in vitro are characterized by increases in total protein content, increased cell size and up-regulation of fetal genes including atrial natriuretic peptide and B-type natriuretic peptide [3]. Initiation of translation, peptide chain elongation and translation termination are the main stages of protein synthesis. Increased rates of protein synthesis in cardiomyocytes correlate with an increase of activity of translation initiation factors [3].
UAP56 is an ATP dependent RNA helicase that also has ATPase activity [4], [5], utilizing the energy derived from ATP hydrolysis to unwind double stranded RNA. UAP56 is a DExD/H box protein and is phylogenetically grouped with eukaryotic initiation factor eIF4A, the prototypical member of the DExD/H box family of helicases [5], [6], [7]. UAP56 was initially identified in an analysis of genes centromeric to HLA-B in the human major histocompatibility complex and was named BAT1 (HLA-B associated transcript 1) [8]. BAT1 was rediscovered as an essential RNA splicing factor and renamed UAP56 [9]. UAP56 is required for spliceosome assembly and mRNA export from the nucleus to the cytoplasm [10], [11], [12]. Binding of ATP to lysine 95 (K95) of UAP56 is required for mRNA export [11]. Depletion of HEL, the Drosophila equivalent of UAP56 has been shown to inhibit protein synthesis [10]. Given the role of UAP56 in RNA splicing and mRNA export, we hypothesized that UAP56 plays an important role in protein synthesis and subsequent hypertrophy. In the present study we found that UAP56 regulates protein synthesis and cardiomyocyte growth an effect that is blocked by helicase dead mutant UAP56.
Section snippets
Methods
Cell culture. Neonatal rat cardiomyocytes were isolated from the cardiac ventricles of 2- to 3-day-old Sprague–Dawley rat neonates as described previously [13]. Briefly, the ventricular tissue parts were excised and rinsed in Hank’s balanced salt solution (HBSS) prior to digestion with multiple rounds of collagenase type II (Worthington). Cells were collected by centrifugation, resuspended in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS), 100 IU/ml penicillin
UAP56 increases protein synthesis in HeLa cells
To assess the effect of UAP56 on protein synthesis, WT UAP56 was overexpressed in HeLa cells and [3H] leucine incorporation was measured. In cells stimulated with 20% FBS, WT UAP56 increased protein synthesis 2.0 ± 0.27-fold compared with control vector (Fig. 1A). We next examined the effect of UAP56 lysine 95 mutants on protein synthesis. Lysine 95 of UAP56 is part of motif I, a conserved DExD/H box protein motif that is important for the helicase and ATPase activity of UAP56 (Fig. 1B) [16].
Discussion
This is the first report to show that UAP56 is an important regulator of protein synthesis and cellular hypertrophy. The results presented here demonstrate that overexpression of UAP56 increases protein synthesis while the knockdown of UAP56 inhibits it. The results with UAP56 mutants also suggest that ATP binding and the ATPase and helicase activity of UAP56 are important in the regulation of protein synthesis. These findings are consistent with other reports showing that UAP56 plays an
Sources of funding
This study was supported by NIH Grant HL80938 to J.D.A.
Disclosures
None.
References (31)
- et al.
The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family
Genomics
(1995) - et al.
Biochemical characterization of the ATPase and helicase activity of UAP56, an essential pre-mRNA splicing and mRNA export factor
J. Biol. Chem.
(2007) - et al.
The DExD/H box protein HEL/UAP56 is essential for mRNA nuclear export in Drosophila
Curr. Biol.
(2001) - et al.
Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells
J. Biol. Chem.
(1997) - et al.
The DEAD-box protein family of RNA helicases
Gene
(2006) - et al.
Topology and regulation of the human eIF4A/4G/4H helicase complex in translation initiation
Cell
(2009) - et al.
The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1
Mol. Cell
(2008) - et al.
Nuclear localization of poly(A)+ mRNA following siRNA reduction of expression of the mammalian RNA helicases UAP56 and URH49
Gene
(2006) - et al.
UAP56 RNA helicase is required for axis specification and cytoplasmic mRNA localization in Drosophila
Dev. Biol.
(2008) - et al.
Signaling pathways for cardiac hypertrophy and failure
N. Engl. J. Med.
(1999)
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
Circulation
Cardiac hypertrophy: a matter of translation
Clin. Exp. Pharmacol. Physiol.
The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production
Genes Cells
Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF-4A
EMBO J.
A new cluster of genes within the human major histocompatibility complex
Science
Cited by (25)
Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control
2015, Journal of ProteomicsCitation Excerpt :We found that the expression of DEAD box UAP56 helicase was down-regulated in TF-silenced cells. UAP56 is an important factor for spliceosome assembly, mRNA export and translation, and it plays an important role in cell growth and proliferation [36–38]. DDX39, a paralogue of UAP56 that is expressed in a growth-regulated manner [39,40], was also down-regulated after TF silencing.
UAP56 is an important mediator of Angiotensin II/platelet derived growth factor induced vascular smooth muscle cell DNA synthesis and proliferation
2013, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Cells were treated with PDGF R&D Systems and Ang II (MP Biomedicals) as described in individual experiments. For siRNA experiments, VSMC were transfected as previously described [13] with UAP56 siRNA oligonucleotides (Dharmacon-Smart pool) using Lipofectamine RNAiMAX (Invitrogen). Measurement of [3H] thymidine incorporation into DNA was performed as previously described [5,14].
UAP56 is a novel interacting partner of Bcr in regulating vascular smooth muscle cell DNA synthesis
2012, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Bcr WT plasmid was prepared as described previously [5]. For transient expression experiments, cells were transfected with Lipofectamine 2000 (Invitrogen) as previously described [13]. For siRNA experiments, VSMC were transfected with control or UAP56 siRNA oligonucleotides (Dharmacon) using Lipofectamine RNAiMAX reagent (Invitrogen).
Analyzing ATP utilization by DEAD-box RNA helicases using kinetic and equilibrium methods
2012, Methods in Enzymology